Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF: Cell
Resistance to RAF Inhibitors Revisited - ScienceDirect
BRAF Alterations in Primary Brain Tumors - Stefania Maraka - Discovery Medicine
Drug resistance in targeted cancer therapies with RAF inhibitors
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
PDF] BRAF Mutation in Hairy Cell Leukemia | Semantic Scholar
The stability of R-spine defines RAF inhibitor resistance: A comprehensive analysis of oncogenic BRAF mutants with in-frame insertion of αC-β4 loop | Science Advances
B-Raf and the inhibitors: from bench to bedside | Journal of Hematology & Oncology | Full Text
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers - ScienceDirect
Targeting BRAF Mutation Positive Cancers: Melanoma, Lung and Colorectal | Roswell Park Comprehensive Cancer Center - Buffalo, NY
Blockade of RAF and autophagy is the one-two punch to take out Ras | PNAS